Multi-omics analyses reveal distinct molecular characteristics and transformation mechanisms of stage I-III micropapillary lung adenocarcinoma

被引:0
|
作者
Qu, Yang [1 ]
Feng, Xiaoli [1 ]
Chen, Hanlin [2 ]
Tan, Fengwei [3 ]
Shao, Anqi [4 ]
Pang, Jiaohui [2 ]
Xue, Qi [3 ]
Zheng, Bo [1 ]
Zheng, Wei [3 ]
Ou, Qiuxiang [2 ]
Gao, Shugeng [3 ]
Shao, Kang [3 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Canc, Natl Canc Ctr, Dept Pathol,Canc Hosp, Beijing, Peoples R China
[2] Nanjing Geneseeq Technol Inc, Nanjing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Canc, Natl Canc Ctr, Dept Thorac Surg,Canc Hosp, Beijing 100021, Peoples R China
[4] Columbia Univ, Vagelos Coll Phys & Surg, Irving Med Ctr, Dept Dermatol, New York, NY USA
来源
关键词
micropapillary lung adenocarcinoma; microdissection; next-generation sequencing; RNA sequencing; transformation; recurrence-free survival; INTERNATIONAL ASSOCIATION; CLASSIFICATION; PROGNOSIS; EGFR; SURVIVAL; PATTERN;
D O I
10.1002/path.6416
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The micropapillary (MIP) pattern is a high-grade histological subtype of lung adenocarcinoma (LUAD) with poor prognosis. In this study, surgically resected tumor samples from 101 patients with stage I-III MIP-LUAD (MIP >= 30%) were microdissected to separate MIP components from non-MIP components, all of which underwent RNA and DNA whole-exome sequencing (WES). The genomic and transcriptomic landscapes of MIP and non-MIP components within MIP-enriched tumor tissues demonstrated remarkable similarities, notably marked by high epidermal growth factor receptor (EGFR) alteration frequencies. However, when compared to MIP-na & iuml;ve LUAD tissues, MIP components showed higher chromosomal instability and revealed 18 enriched alterations, encompassing EGFR mutations, EGFR amplifications, and CDKN2A/CDKN2B deletions, which all linked to upregulation of cell proliferation pathways and downregulation of immune pathways. Shared mutations were observed in 97.8% (91/93) of patients with paired DNA WES data for MIP and non-MIP components within the same tissues, suggesting a common origin. The recurrence-free survival analysis identified MACF1, PCLO, ADGRV1, and Fanconi Anemia pathway mutations as negative indicators. In all, we conducted an in-depth analysis of the molecular characteristics and transformation mechanisms of MIP-LUAD, employing microdissection techniques to investigate the genomic and transcriptomic levels within a substantial cohort, providing insights for precision medicine of this aggressive cancer subtype. (c) 2025 The Pathological Society of Great Britain and Ireland.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Multi-omics analysis of molecular characteristics and transformation mechanisms of stage I-III micropapillary lung adenocarcinoma
    Shao, Kang
    Gao, Shugeng
    Tan, Fengwei
    Shao, Anqi
    Feng, Xiaoli
    Xue, Qi
    Qu, Yang
    Zheng, Bo
    Zheng, Wei
    Chen, Hanlin
    Ou, Qiuxiang
    Tang, Haimeng
    CANCER RESEARCH, 2024, 84 (06)
  • [2] Integrative Multi-Omics Analyses Reveal Molecular Subtypes with Distinct Prognosis of Early-Stage HighGrade Lung Adenocarcinoma
    Liu, B.
    Shi, Y.
    Wu, N.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S142 - S143
  • [3] Multi-Omics Analyses Reveal the Mechanisms of Early Stage Kidney Toxicity by Diquat
    Zhang, Huazhong
    Zhang, Jinsong
    Li, Jinquan
    Mao, Zhengsheng
    Qian, Jian
    Zong, Cheng
    Sun, Hao
    Yuan, Beilei
    TOXICS, 2023, 11 (02)
  • [4] Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung Adenocarcinoma
    Huang, Ziqi
    Li, Baihui
    Guo, Yan
    Wu, Lei
    Kou, Fan
    Yang, Lili
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [5] Multi-omics Analyses Reveal the Mechanisms of Ultra-early Stage Kidney Toxicity by Diquat
    Zhang, H.
    Zhang, J.
    Li, J.
    Mao, Z.
    Qian, J.
    Zong, C.
    Sun, H.
    Yuan, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [6] Multi-omics and clustering analyses reveal the mechanisms underlying unmet needs for patients with lung adenocarcinoma and identify potential therapeutic targets
    Asada, Ken
    Kaneko, Syuzo
    Takasawa, Ken
    Shiraishi, Kouya
    Shinkai, Norio
    Shimada, Yoko
    Takahashi, Satoshi
    Machino, Hidenori
    Kobayashi, Kazuma
    Bolatkan, Amina
    Komatsu, Masaaki
    Yamada, Masayoshi
    Miyake, Mototaka
    Watanabe, Hirokazu
    Tateishi, Akiko
    Mizuno, Takaaki
    Okubo, Yu
    Mukai, Masami
    Yoshida, Tatsuya
    Yoshida, Yukihiro
    Horinouchi, Hidehito
    Watanabe, Shun-Ichi
    Ohe, Yuichiro
    Yatabe, Yasushi
    Kohno, Takashi
    Hamamoto, Ryuji
    MOLECULAR CANCER, 2024, 23 (01)
  • [7] Multi-omics analyses reveal biological and clinical insights in recurrent stage I non-small cell lung cancer
    Wang, Chengdi
    Li, Jingwei
    Chen, Jingyao
    Wang, Zhoufeng
    Zhu, Guonian
    Song, Lujia
    Wu, Jiayang
    Li, Changshu
    Qiu, Rong
    Chen, Xuelan
    Zhang, Li
    Li, Weimin
    NATURE COMMUNICATIONS, 2025, 16 (01)
  • [8] Histopathological Images and Multi-Omics Integration Predict Molecular Characteristics and Survival in Lung Adenocarcinoma
    Chen, Linyan
    Zeng, Hao
    Xiang, Yu
    Huang, Yeqian
    Luo, Yuling
    Ma, Xuelei
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [9] Multi-omics analyses reveal molecular mechanisms for the antagonistic toxicity of carbon nanotubes and ciprofloxacin to Escherichia coli
    Deng, Rui
    Gao, Xuan
    Hou, Jie
    Lin, Daohui
    SCIENCE OF THE TOTAL ENVIRONMENT, 2020, 726
  • [10] Multi-omics analysis of molecular landscape and heterogeneity in fetal adenocarcinoma of the lung
    Guo, Wei
    Sun, Li
    Chen, Xiaoxi
    Zhou, Haitao
    Yan, Shi
    Zhao, Gang
    Tang, Haimeng
    Bao, Hua
    Wu, Xue
    Shao, Yang
    Lin, Lin
    CANCER RESEARCH, 2023, 83 (07)